Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $71.43M in the quarter ending March 31, 2026, with 44.82% growth. This brings the company's revenue in the last twelve months to $285.61M, up 34.29% year-over-year. In the year 2025, Iovance Biotherapeutics had annual revenue of $263.50M with 60.60% growth.

• Revenue (ttm): $285.61M
• Revenue Growth: +34.29%
• P/S Ratio: 5.66
• Revenue / Employee: $292,931
• Employees: 975
• Market Cap: 1.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	263.50M	99.43M	60.60%
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error